Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles, respectively, in the development and regulation of skeletal muscle mass. The findings of Sun et al. in this issue shed light on the potential regulation and actions of this yin-and-yang system in uremic sarcopenia and the salutary effects of exercise
Age-related skeletal muscle sarcopenia is linked with increases in falls, fractures, and death and t...
Myostatin, a member of the transforming growth factor-β superfamily, is a potent negative regulator ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Resistance to growth hormone (GH)-induced insulin-like growth factor-1 (IGF-1) gene expression contr...
Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles,...
“Uremic sarcopenia” refers to a progressive decrease in muscle mass, strength, and function despite ...
Skeletal muscle is an extremely plastic tissue for its ability to respond to different stimuli such ...
BACKGROUND: Sarcopenia increases as renal function declines and is associated with higher morbidity ...
Myostatin is a member of the transforming growth factor (TGF)-β superfamily. It is expressed by anim...
Myostatin is a secreted growth and differentiating factor that belongs to TGF-bsuper-family. Myostat...
Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may functi...
Sarcopenia, the age-related loss of muscle mass and strength, represents one of the mai...
Skeletal muscle comprises approximately 40 % of body weight, and is important for locomotion, as wel...
International audienceMyostatin is an endogenous, negative regulator of muscle growth determining bo...
International audienceMyostatin is a member of the TGF beta family which plays a major role in negat...
Age-related skeletal muscle sarcopenia is linked with increases in falls, fractures, and death and t...
Myostatin, a member of the transforming growth factor-β superfamily, is a potent negative regulator ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Resistance to growth hormone (GH)-induced insulin-like growth factor-1 (IGF-1) gene expression contr...
Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles,...
“Uremic sarcopenia” refers to a progressive decrease in muscle mass, strength, and function despite ...
Skeletal muscle is an extremely plastic tissue for its ability to respond to different stimuli such ...
BACKGROUND: Sarcopenia increases as renal function declines and is associated with higher morbidity ...
Myostatin is a member of the transforming growth factor (TGF)-β superfamily. It is expressed by anim...
Myostatin is a secreted growth and differentiating factor that belongs to TGF-bsuper-family. Myostat...
Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may functi...
Sarcopenia, the age-related loss of muscle mass and strength, represents one of the mai...
Skeletal muscle comprises approximately 40 % of body weight, and is important for locomotion, as wel...
International audienceMyostatin is an endogenous, negative regulator of muscle growth determining bo...
International audienceMyostatin is a member of the TGF beta family which plays a major role in negat...
Age-related skeletal muscle sarcopenia is linked with increases in falls, fractures, and death and t...
Myostatin, a member of the transforming growth factor-β superfamily, is a potent negative regulator ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...